Histocell Regenerative Medicine S.L. of Derio at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine

Histocell Regenerative Medicine S.L.

Parque Tecnológico 801A, 2º, 48160 Derio
Telephone +34 94 6567900
Fax +34 94 4036999

This company is co-exhibitor of
FENIN Federacion Espanola de Empresas de Tecnologia Sanitaria

Hall map

MEDICA 2018 hall map (Hall 15): stand F21

Fairground map

MEDICA 2018 fairground map: Hall 15

Our range of products

Product categories

  • 05  Commodities and Consumer Goods
  • 05.15  Wound care equipment
  • 05.15.06  Other bandages, dressings and accessories

Other bandages, dressings and accessories

Our products

Product category: Other bandages, dressings and accessories


REOXCARE® is used in the treatment of chronic or acute skin ulcers and diabetic foot ulcers in which the rest of products have failed. REOXCARE® is the first dressing that addresses the key factor of antioxidation as an accelerator of natural healing of chronic wounds. The differential benefits of the product have been proved in numerous postmarketing studies, showing health and economic advantages, saving over the 50% of medical cost comparing to conventional treatments. REOXCARE® is been commercialised in several European and South American countries and has already been approved for registration in various Asiatic countries. The company sought to expand its market scope looking for new commercial partners who are seek to progress at the wound care domain.

More Less

About us

Company details

 Histocell is a leading private biopharmaceutical company dedicated to the discovery, development and commercialization of new medical devices, active ingredients and cell therapies in the field of Regenerative Medicine. Since September 2018 Histocell is also dedicated to the manufacturing of its own products at newly built 2,065 m2 / 21,500 feet2 fully equipped production facilities in the heart of Bilbao’s technology valley.

Its products are distinguished by their common therapeutic approach focused on the protection and regeneration of tissues damaged by oxidative and inflammatory environments and are backed up by a strong intellectual protection with 46 patents so far. Histocell is now looking for commercial partners for the distribution of its main medical device, REOXCARE®, a natural-based dressing for hard-to-heal wounds launched at the beginning of 2017.

More Less